Corona Remedies IPO opens December 8 with price band set for ₹655 crore OFS

At the top of the price band, Corona Remedies is expected to command a post-listing market capitalisation of ₹6,495 crore.

Leave a Reply

Your email address will not be published. Required fields are marked *